Back to results
US 2004/0082627 A1Published application
Certain aromatic monocycles as kinase modulators
OwnerJames W. Darrow, Robert W. DeSimone +2inventors
InventorsJames W. Darrow, Robert W. DeSimone, Douglas A. Pippin, Scott A. Mitchell
Life of this patent
Estimating the term…
Abstract
Compound having Formula 1: 1 wherein W is a monocyclic ring having the structure 2 are useful as modulators of kinase activity.
Claims31
A compound having Formula 1:
- 39
- a pharmaceutically acceptable salt, hydrate, solvate, crystal form, diastereomer, prodrug, or mixture thereof, wherein one or two of R1, R2, and R3 may each independently be hydrogen;
- straight or branched chain (C1-C7)alkyl, in which the branched alkyl chains are allowed to also form a 3-7 member heteroalkyl or alkyl ring;
- (cyclo(C3-C6)alkyl)methyl;
- (C1-C6)alkoxy;
- (C1-C6)alkyloxy(C1-C6)alkoxy;
- or sulfonamide, and
- R1, R2, and R3 may each independently be
- mono- or di((C1-C6)alkyl)amino, wherein the alkyl group may be unsubstituted, mono- di-, or tri-substituted with phenyl, (C1-C7)alkoxy or phenoxy, further wherein the phenyl and/or phenoxy may be unsubstituted or substituted with hydroxy, nitro, cyano, amino, halogen, straight or branched chain (C1-C7)alkyl or (C1-C6)alkoxy;
- phenyl, benzyl, or heteroaryl which may be unsubstituted, mono-, di-, or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, acetyl, phenyl which may be unsubstituted or substituted with one or more of (C1-C7)alkyl, (C1-C7)alkoxy, hydroxy, nitro, oxo, cyano, amino, or halogen, (C1-C6)alkoxy, (C1-C6)alkyloxy(C1-C6)alkoxy, mono- or di((C1-C6)alkyl)amino, mono- or di((C1-C6)alkyl)amino(C1-C6)alkyl, amino(C1-C6)alkyl, (C1-C6)alkyl which may be unsubstituted or substituted with one or more of hydroxy, nitro, oxo, cyano, amino, or halogen, or heteroaryl which may be bonded through an ether, sulfide, or oxo group;
- heteroaryloxy or phenoxyphenyl where each heteroaryl or phenyl may be independently unsubstituted, mono-, di-, or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, sulfonamide, (C 1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkyloxy-(C1-C6)alkoxy, mono- or di((C1-C6)alkyl)amino, or amino(C1-C6)alkyl;
- 4-phenyl- or 4-heteroaryl-1-piperazinyl where the phenyl or heteroaryl ring may be independently unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, sulfonamide, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkyloxy-(C1-C6)alkoxy, mono- or di((C1-C6)alkyl)amino, mono- or di((C1-C6)alkyl)amino(C1-C6)alkyl);
- n is 0 or 1;
- Z1, Z2 and Z3 are each independently
- 40
- wherein
- X is C or S;
- and
- R4—R10 are independently
- hydrogen;
- straight or branched chain (C1-C6)alkyl;
- phenyl or benzyl which may each independently be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkyloxy-(C1-C6)alkoxy, mono- or di((C1-C6)alkyl)amino, amino(C1-C6)alkyl;
- or
- heteroaryl which may be unsubstituted, mono-, di- or trisubstituted with one or more of hydroxy, nitro, cyano, amino, halogen, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkyloxy-(C1-C6)alkoxy, mono- or di((C1-C6)alkyl)amino, amino(C1-C6)alkyl;
- each m is independently 0 or 1;
- and
- W is a monocyclic ring having the structure
- 41
25 more elements
Dependencies are inferred from the claim text.